InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
82.87
(
1.08%
)
Bitcoin
70,367.60
(
2.71%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

rocky301

Send PM Follow Ignore
Followers 110
Posts 6480
Boards Moderated 0
Alias Born 05/01/2003

rocky301

Re: farviewhill post# 33755

Wednesday, 09/14/2011 4:09:24 PM

Wednesday, September 14, 2011 4:09:24 PM

Post# of 92948

There was a mention, I believe made by Rabin, I believe, that within a year, the commercial prospects, i.e. revenue for ACTC, will compare to and surpass Lipitor.



On the contrary, at yesterdays meeting he specifically stated that any significant revenues won't happen for "a couple of few years out" and that most likely will be with compassionate use, possibly in Europe. The commercial side of the money maker dryAMD(Lipitor numbers) are further out yet.

23:50 time mark here:
http://www.wsw.com/webcast/rrshq20/actc/
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up